JP2020514342A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514342A5
JP2020514342A5 JP2019549378A JP2019549378A JP2020514342A5 JP 2020514342 A5 JP2020514342 A5 JP 2020514342A5 JP 2019549378 A JP2019549378 A JP 2019549378A JP 2019549378 A JP2019549378 A JP 2019549378A JP 2020514342 A5 JP2020514342 A5 JP 2020514342A5
Authority
JP
Japan
Prior art keywords
oil
formulation according
polyoxyethylene
ethoxylated
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514342A (ja
JP7250689B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2018/050265 external-priority patent/WO2018163176A1/en
Publication of JP2020514342A publication Critical patent/JP2020514342A/ja
Publication of JP2020514342A5 publication Critical patent/JP2020514342A5/ja
Application granted granted Critical
Publication of JP7250689B2 publication Critical patent/JP7250689B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549378A 2017-03-07 2018-03-07 活性化合物のための局所送達系 Active JP7250689B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762467863P 2017-03-07 2017-03-07
US62/467,863 2017-03-07
PCT/IL2018/050265 WO2018163176A1 (en) 2017-03-07 2018-03-07 Topical delivery systems for active compounds

Publications (3)

Publication Number Publication Date
JP2020514342A JP2020514342A (ja) 2020-05-21
JP2020514342A5 true JP2020514342A5 (https=) 2022-12-27
JP7250689B2 JP7250689B2 (ja) 2023-04-03

Family

ID=61692208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549378A Active JP7250689B2 (ja) 2017-03-07 2018-03-07 活性化合物のための局所送達系

Country Status (8)

Country Link
US (2) US20210137829A1 (https=)
EP (1) EP3592336A1 (https=)
JP (1) JP7250689B2 (https=)
CN (1) CN110545796A (https=)
AU (1) AU2018231842B2 (https=)
CA (1) CA3055159A1 (https=)
IL (1) IL268773B2 (https=)
WO (1) WO2018163176A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3076555B1 (fr) * 2018-01-11 2020-01-24 Jafer Enterprises R&D Sl Materiau polymerique solide impregne d'une substance organique volatile et d'un ester particulier et ses utilisations
EP3893832A1 (en) 2018-12-14 2021-10-20 Mary Kay, Inc. Cosmetic compositions
US20220304940A1 (en) * 2019-06-20 2022-09-29 Lyotropic Delivery Systems Ltd. Polymeric soft films embedded with nanodomains and/or a bioactive and methods of producing same
WO2021056522A1 (en) * 2019-09-29 2021-04-01 L'oreal Cosmetic composition for caring for keratin materials
CN110960682B (zh) * 2019-12-13 2020-12-25 厦门大学 一种pH调控凝胶高压后融化态时长增强药物负载的方法
US20230113554A1 (en) * 2019-12-16 2023-04-13 Ao Technology Ag Non-stick antibiotic gels
CN111632191B (zh) * 2020-05-11 2021-12-17 西安理工大学 一种释药磷酸钙基骨水泥的制备方法
AU2021411493B2 (en) * 2020-12-29 2025-07-24 Kao Usa Inc. Hair shine compositions
EP4112043A1 (en) * 2021-06-30 2023-01-04 GSK Consumer Healthcare SARL Nano-complex composition comprising diclofenac
CN113786382B (zh) * 2021-11-04 2024-05-28 浙江得恩德制药股份有限公司 一种盐酸特比萘芬凝胶及制备方法
EP4342450A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic topical diclofenac formulations
EP4342449A1 (en) * 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic single phase gel compositions for topical delivery of diclofenac
CN116935988A (zh) * 2023-08-02 2023-10-24 华中科技大学 一种用于捕集二氧化碳的有机胺相变吸收体系设计方法
WO2025062440A1 (en) * 2023-09-20 2025-03-27 Pulse Pharmaceuticals Pvt. Ltd Topical nano-dispersion compositions and their preparation thereof
US20250099369A1 (en) * 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs
WO2025153330A1 (en) * 2024-01-15 2025-07-24 JeNaCell GmbH Microemulsion systems for the incorporation of poorly-water soluble compounds into bacterial cellulose
WO2025193822A1 (en) * 2024-03-13 2025-09-18 Menning Mark Michael Aqueous compositions of poorly water-soluble compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660554B1 (fr) * 1990-04-05 1992-07-03 Oreal Composition cosmetique ou dermo-pharmaceutique aqueuse contenant en suspension des spherouides hydrates d'une substance lipidique hydrophile.
AU2259692A (en) 1991-07-03 1993-02-11 Sano Corporation Composition and method for transdermal delivery of diclofenac
WO1997042944A1 (en) 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Topical composition
US7182950B2 (en) 2002-06-12 2007-02-27 Nutralease Ltd. Nano-sized self-assembled liquid dilutable vehicles
EP1598060A1 (en) 2004-05-18 2005-11-23 Nestec S.A. Oil-in-water emulsion for delivery
JP2009516724A (ja) 2005-11-22 2009-04-23 ネステク ソシエテ アノニム 水中油型エマルション及び機能性送達のためのその使用
CA2629913A1 (en) 2005-12-09 2007-06-14 Cerecon Ag Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
WO2008058366A1 (en) 2006-09-28 2008-05-22 Université de Montréal Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
GB0704846D0 (en) 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
DK2211837T3 (da) 2007-06-08 2014-02-10 Troikaa Pharmaceuticals Ltd Ikke-vandig topikal opløsning af diclofenac og fremgangsmåde til fremstilling deraf
EP2055298A1 (en) 2007-10-30 2009-05-06 Novartis AG Topical composition
US20100099766A1 (en) 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
SG10201401297QA (en) 2009-04-08 2014-08-28 Cadila Healthcare Ltd Stable pharmaceutical compositions of diclofenac
CN102151268B (zh) * 2011-03-28 2012-10-17 王义明 一种治疗阿尔茨海默症的复方制剂及其制备方法
CA2878784A1 (en) 2012-07-12 2014-01-16 Ferring B.V. Diclofenac formulations
CN103655459A (zh) * 2013-12-19 2014-03-26 中国药科大学 一种多功能微乳凝胶制剂及其制备工艺
US11000495B2 (en) * 2014-09-10 2021-05-11 GSK Consumer Healthcare S.A. Topical diclofenac sodium compositions
CN113788831B (zh) * 2021-10-15 2023-01-17 常州大学 二氢吲嗪并吡咯酮衍生物及类似物及其合成方法

Similar Documents

Publication Publication Date Title
JP2020514342A5 (https=)
AU2014359195B2 (en) Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
US20220257510A1 (en) Compositions for Nanoemulsion Delivery Systems
Kim et al. Transdermal delivery systems in cosmetics
Esposito et al. Nanomedicines to treat skin pathologies with natural molecules
KR102569534B1 (ko) 식물 공급원으로부터 칸나비노이드의 선택적 추출 방법
EP0833573B1 (fr) Vehicules de principes actifs a base de tensioactifs non ioniques et leurs applications notamment dans les domaines alimentaire, cosmetique et pharmaceutique
Bajerski et al. The use of Brazilian vegetable oils in nanoemulsions: an update on preparation and biological applications
Dobreva et al. Natural lipids as structural components of solid lipid nanoparticles and nanostructured lipid carriers for topical delivery
D’Souza et al. Nanostructured lipid carriers (NLCs) for drug delivery: Role of liquid lipid (oil)
CN1658770A (zh) 纳米尺寸自组装结构的液体
JP2013508296A5 (https=)
JP2009533341A5 (https=)
US20150190372A1 (en) Microcapsules containing retinoids, method of preparing same, and pharmaceutical compositions containing same
RU2011148140A (ru) Самомикроэмульгирующаяся оральная фармацевтическая композиция, содержащая гидрофильное лекарственное средство, и способ ее приготовления
JP2012524771A5 (https=)
FR3013218A1 (fr) Composition comprenant des capsules gelifiees stabilisees par un tampon
JP2010531684A5 (https=)
US20240180818A1 (en) Skin care formulations with hydrophilic active ingredient
CN1286529C (zh) 具有皮肤靶向性的药物组合物及其制备方法和用途
RU2019129711A (ru) Системы доставки для местного нанесения для активных веществ
Špaglová et al. Development strategy of dermal and transdermal formulation: synergistic effect of chemical penetration enhancers
EP3110392A1 (de) Topische kosmetische oder pharmazeutische zusammensetzung
CN103655217B (zh) 一种原花青素微乳眼霜及其制备方法
RU2777644C2 (ru) Системы доставки для местного нанесения для активных веществ